Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blinded Randomized Study of Ephedrine 0.15 mg/kg for Reducing Onset Time of Rocuronium 0.6 mg/kg in Elderly Patients (≥ 80 Years)

NCT06681662 is registered in ClinicalTrials.gov with Matias Vested as lead sponsor.

NCT NCT06681662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blinded Randomized Study of Ephedrine 0.15 mg/kg for Reducing Onset Time of Rocuronium 0.6 mg/kg in Elderly Patients (≥ 80 Years)
Lead sponsor
Matias Vested
Phase
Phase 4
Overall status
Completed
Start date
January 13, 2025
Completion date
October 5, 2025
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade